What is “Actoplus Met” in the USA?
“Actoplus Met” is the brand name for a combination diabetes medicine that contains pioglitazone + metformin. It’s used to help control blood sugar in people with type 2 diabetes [1].
Is Actoplus Met currently sold in the USA?
I can’t confirm current US availability from the information provided here. Brand names and formulations can change over time (for example, shifts to generic or different branded versions), so it helps to check what’s on your prescription label or your local pharmacy inventory.
What’s the typical role of Actoplus Met (pioglitazone/metformin)?
This combination is used when blood sugar is not well controlled with diet, exercise, and/or other diabetes medications. Metformin mainly lowers glucose production in the liver, and pioglitazone improves insulin sensitivity [1].
What should patients know about side effects or safety?
Key safety considerations for pioglitazone-based regimens include the risk of fluid retention/edema and potential weight gain. Metformin has its own key considerations, including gastrointestinal side effects for many people. If you tell me your age, kidney status (any history of kidney disease), and whether you take other diabetes drugs, I can help you identify the most relevant questions to ask your clinician.
Is there a generic equivalent in the US?
Actoplus Met’s components (pioglitazone and metformin) are widely available as generics, though the exact combination in one tablet can vary by manufacturer and country. Ask your pharmacist whether your prescription can be filled as an equivalent generic combination.
---
Sources
[1] https://www.drugs.com/actoplus-met.html